Gastrointestinal cancer
Explore our latest news, features and educational resources in this specialist area.
SMC accepts treatment for colorectal cancer
Pembrolizumab is accepted for restricted use within NHS Scotland.
SMC accepts treatment for oesophageal carcinoma
Nivolumab (Opdivo®) is accepted for use within NHS Scotland.
Patients with cholangiocarcinoma set to benefit from life extending treatment
Some people who have cholangiocarcinoma are now set to benefit from life-extending treatment pemigatinib after NICE published final draft guidance recommending it.
#VisualAbstract: Combination therapy using conformation-specific KIT inhibitors associated with clinical benefit in patients with advanced gastrointestinal stromal tumors
SMC accepts treatment for hepatocellular carcinoma
Atezolizumab is accepted for use within NHS Scotland for adult with advanced or unresectable disease who have not received prior systemic therapy.